Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer Journal Articles Refereed uri icon

Overview

Published in

  • British Journal of Cancer

Time

Date/time value

  • 2010

Identity

Digital Object Identifier (DOI)

  • 10.1038/sj.bjc.6605798

Additional Document Info

Parent Title

  • BRITISH JOURNAL OF CANCER

Volume

  • 103

Issue

  • 4

Publisher

  • Nature Publishing Group